Nanoscale study reveals 135-fold electroluminescence enhancement in deprotonated phthalocyanine via intermolecular energy transfer, indicating a method to bypass charge-injection limits in OLEDs.
Manipulating the electroluminescence of organic molecules is important for the development of advanced organic light-emitting diodes (OLEDs). Here, we demonstrate a single-molecule sensitization strategy to brighten an otherwise-weak molecular emitter by using the scanning tunneling microscope induced luminescence (STML) technique. We show that while the free-base phthalocyanine (H2Pc) molecule is a bright emitter, the molecule upon double deprotonation ([Pc]2−) exhibits electroluminescence that is suppressed by three orders of magnitude. The extremely weak emission of [Pc]2− is traced to a misalignment of its frontier orbitals with the substrate, which fundamentally shifts the excitation from an efficient carrier-injection mechanism in H2Pc to an inefficient inelastic electron scattering process in [Pc]2−. However, by bringing a zinc-phthalocyanine (ZnPc) molecule close to it to form a donor–acceptor dimer (ZnPc–[Pc]2−), we introduce an intermolecular energy transfer pathway that enhances the luminescence of [Pc]2− by approximately 135-fold. Furthermore, combined with theoretical calculations, the dependence of STML spectra on the intermolecular distances (d) indicates that the energy-transfer mechanism is dominated by Förster resonance energy transfer. Our findings demonstrate a viable strategy for overcoming molecular-level charge-injection limitations and provide actionable guidelines for designing OLED architectures with enhanced luminescence efficiency.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: